Figure 1.
OS in patients aged <65 years with stage II to IV PTCL. (A-B) OS according to 2 calendar periods (1989-2008 and 2009-2018) (A) and according to histologic subtypes ALK− ALCL, ALK+ ALCL, ALCL NOS, AITL, and PTCL NOS (B).
OS in patients aged <65 years with stage II to IV PTCL. (A-B) OS according to 2 calendar periods (1989-2008 and 2009-2018) (A) and according to histologic subtypes ALK− ALCL, ALK+ ALCL, ALCL NOS, AITL, and PTCL NOS (B).